Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV002248270 | SCV002520288 | pathogenic | not provided | 2022-05-16 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 25525159, 17603795) |
Labcorp Genetics |
RCV005095840 | SCV005839482 | pathogenic | Wilms tumor 1 | 2024-03-28 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg254*) in the GPC3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GPC3 are known to be pathogenic (PMID: 10402475, 12713262, 17603795). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with clinical features of Simpson-Golabi-Behmel syndrome (PMID: 17603795). ClinVar contains an entry for this variant (Variation ID: 1686763). For these reasons, this variant has been classified as Pathogenic. |